Objective. This study measured the reliability of the Behçet's Disease Current Activity Form (BDCAF) questionnaire used as a patient self-report form. Methods. A study was conducted among 63 patients with Behçet's disease who attended our rheumatology clinic. First, a physician administered a BDCAF questionnaire. Second, the patient completed a self-administered questionnaire at home within 24 hours of the visit. The test-retest reliability was analyzed using kappa tests. Kappa scores of ＞0.6 indicated good agreement. The BDCAF score was compared with the patient's/clinician's perception of disease activity and the Korean version of Behçet's Disease Quality of Life (BDQOL). Results. The study included 17 males and 46 females. The mean age of participants was 47.7 years and the mean disease duration was 5.3 years at the first assessment. Fifty-three patients (84.1%) returned the questionnaires to us by mail. For test-retest reliability, good agreement was achieved with the items including headache, oral/genital ulceration, erythema, arthritis, and diarrhea with altered/frank blood per rectum; moderate agreement with skin pustules, arthralgia, and eye involvement; fair agreement with nausea/vomiting/abdominal pain, nervous system, and major vessel involvement. Significant associations were observed between BDCAF scores with the patient's/clinician's perception of disease activity and BDQOL (p＜0.05). Conclusion. The BDCAF appears useful as a patient self-report instrument for assessment of disease status. 
INTRODUCTION
Behçet's disease (BD) is a chronic, multisystem disorder that is a fluctuant chronic disease like rheumatoid arthritis (RA). It is difficult to define the disease activity in BD [1, 2] . We validated a Korean version of Behçet's Disease Current Activity Form (BDCAF) [3] from the revised version of 2006 (http://www.behcet.ws) of original study [4] . The Iranian Behçet's Disease Dynamic Activity measure (IBDDAM) and BDCAF are the most widely used indices in BD, but are designed for administration by physicians, who are usually pressed for time during busy clinics [5] . Behçet's Syndrome Activity Score (BSAS) is a patient-administered measure [6] . Self-assessment tools, especially in RA, are advantageous in clinical practice [7, 8] , but many physicians consider a patient questionnaire subjective, not an objective tool [8] . This study evaluated the reliability of BDCAF as a patient-derived measure.
MATERIALS AND METHODS
Sixty-three patients with BD were collected prospectively from March 2013 through August 2013. All patients were older than 18 years and fulfilled the criteria of International Study Group for BD or Chang's criteria [9, 10] . All patients agreed to a written informed consent to participate in this study, and the Institutional Review Board of Gachon University Gil Medical Center approved the study protocol. The first BDCAF questionnaire was administered by a physician to the patient during his or her visit to the rheumatology clinic (test 1) and the sec- 
RESULTS
Seventy-three percent (n=46) of the patients were female. The mean age of sixty-three patients was 47.7 years and the mean disease duration was 5.3 years at the first BDCAF assessment. The mean patient VAS was 3.9 and that of physician was 4.1. The mean of transformed BDCAF score was 6.3 and of BDQOL score was 8.6. Fifty-three (84.1%) patients completed the second BDCAF questionnaire. Demographic and clinical characteristics of patients are summarized in Table 1 . There was no stat- Table 2 . Good agreement (kappa scores ＞0.6) was observed for six manifestations of BD: headache, oral/genital ulceration, erythema, arthritis, and diarrhea with altered/frank blood per rectum. Moderate agreement was observed for skin pustules, arthralgia, and eye involvement. For nausea/vomiting/abdominal pain, nervous system, and major vessel involvement, we noted fair agreement.
The test-retest reliability of BDCAF score was good with a high correlation between the time points (Spearman's correlation coefficient, r=0.829, p＜0.001). The BDCAF1 score significantly correlated with patient's VAS (r=0.391, p=0.004), physician's VAS (r=0.366, p=0.010), and BDQOL (r=0.506, p=0.013) at test 1 and BDCAF 2 score also correlated with patients' VAS (r=0.472, p＜0.001) and BDQOL (r=0.389, p=0.013) at test 2 (Table 3 ). There was also good correlation between BDQOL 1 and 2 (r=0.905, p＜0.001).
DISCUSSION
We performed this study to evaluate the reliability of BDCAF as a self-administered measure. BD presents with heterogeneous organ involvement and has a fluctuating course [1] . Quantitative measurement in BD is rare; there is no single gold standard to assess disease activity, and a lack of laboratory tests. With RA, the self-report questionnaire gives a highly reliable quantitative analysis of the disease course, and is simple to administer [7, 8] . Houssien et al. [7] reported that a patient-derived disease activity score (DAS) can substitute for a physician-derived DAS in RA. Kappa analysis showed good agreement between physician and patient assessments of individual joint tenderness. Patient self-reported questionnaires, which take about 10 minutes to complete while waiting to see a physician in routine care, provide valuable data representing clinical status, monitoring disease progression or predicting outcomes. The disadvantages are cultural differences in interpretation of data, literacy requirement, motivation, and possibility of manipulation by patient [8, 12] .
In BD, there are few tools to measure disease activity, especially self-administered measures [6] . We investigated BDCAF as a patient self-report measure, although it was originally was developed for scoring by clinician [4] . We noted good agreement (kappa scores ＞0.6) for most items, but like reports of physician assessment [4, 13, 14] , the agreement of nervous system and major vessel involvement was relative low. There were significant positive correlations between total BDCAF scores and patient's VAS, physician's VAS, and BDQOL at each time, which represent reliability and reproducibility of our study. We conclude that a patient-derived BDCAF gives results comparable to a physician-administered BDCAF, and is correlated with BDQOL and physician/patient's VAS. In addition, we questioned the patients (n=47/50) in our concurrent study [15] , "which questionnaire do you think easy to fill out, BDCAF or BSAS?" 73.1% of patients selected BDCAF, 17.3% BSAS, and 9.6% responded 'I don't know'. Patient-derived BDCAF could as useful in usual clinical practice as the physician-administered BDCAF, with the advantage of not taking physician time. If the only clinical need is monitoring changes in disease activity or in patient function, this self-administered BDCAF may be sufficient. We have some limitations in this study. First, there was a lack of generalizability and possible selection bias because our subjects are patients at one tertiary hospital. Second, because the second assessment occurred within 24 hours after physician-administered BDCAF, the patient's decision might change over time. On the other hand, patient recall could lead to high kappa agreement, although a physician decided and filled out patient's symptoms for each item at the first questionnaire. For more valid test of a self-administered measure, this point should be controlled. Third, unfortunately we did not compare patient-derived BDCAF with BSAS, because BSAS validation work [15] was performed after this study.
CONCLUSION
The patient-derived BDCAF was reliable for measuring current activity in BD patients. It can substitute for a physician-derived BDCAF.
